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Amphotericin B nephrotoxicity: Increased renal resistance and tubule
permeability. Two groups of rats received amphotericin-B (Amp). One
group (AA) received a single acute dose of! mg/kg iv. The second (CA)
received 10mg/kg i.p. daily for 4 days. In AA rats, measurements ito 5
hr after Amp were compared with their own preinfusion values. Inulin
clearance, (C10, 4.5 ml min kg' per kidney pre vs. 1.3 post), renal
plasma flow (RPF, 12.0 ml mm' . kg' vs. 7.4), and the estimated
pressure in the glomerular capillaries (Pgc, 52 mm Hg vs. 40), were all
significantly decreased while renal vascular resistance (5.2 mm Hg/mi
vs. 12.0) was increased. Only 45% of the 3H-inulin injected into surface
tubules was recovered in the urine as contrasted with 100% recovery
before injection. This suggests that tubule permeability was increased,
but there was no histologic evidence of renal tubule necrosis. Twenty-
four hours after intravenous Amp, C10 and RPF returned to normal.
Data from CA rats were compared with values from sham-treated
pairfed (PF) control rats. Again, C1,, (4.22 ml min kg in PF vs.
2.69 in CA), RPF (16.1 ml min kg vs. 8.3), and P. (48mm Hg vs.
38) were decreased, and renal vascular resistance (4.9 mm Hg/mi vs.
8.0) was increased. The recovery of 3H-inulin in the urine was slightly,
but significantly, decreased (96% vs. 83%). These findings demonstrate
that Amp decreases renal function by at least two mechanisms. An
increase in renal vascular resistance is most important, although
increased tubule permeability with a "backleak" of tubule fluid also
contributes to renal dysfunction, particularly after intravenous Amp.
Néphrotoxicité de i'amphotéricine B: Augmentation de Ia résistance
rénale et de Ia perméabilité tubulaire. Deux groupes de rats ont recu de
l'amphotéricine B (Amp). Un groupe (AA) a recu une dose unique aigud
de 1 mg/kg iv. Le second (CA) a recu 10 mg/kg i.p. par jour pendant 4jours. Chez les rats AA, les mesures 1 a 5 hr après Amp ont été
comparées avec leurs propres valeurs avant perfusion. La clearance de
l'inuline (C10, 4,5 ml mn' . kg_I par rein avant contre 1,3 après), Ic
debit plasmatique renal (RPF, 12,0 ml mn' - kg1 contre 7,4), et Ia
pression estimée dans les capillaires glomerulaires (P5, 52 mm Hg
contre 40) étaient tous significativement diminués, tandis que la résist-
ance vasculaire rénale (5,2 mm Hg/mi contre 12,0) était augmentée.
Seulement 45% de Ia 3H-inuline injectée dans les tubules superficiels
était retrouvée dans les urines par opposition b une récupération de
100% avant l'injection. Cela suggere que Ia perméabilité tubulaire était
accrue, mais il n'y avait pas Ia preuve histologique de nécrose tubulaire
rénale. Vingt-quatre heures après Amp intraveineux, C10 et RPF étaient
revenus a Ia normale. Les données des rats CA ont été comparées aux
valeurs obtenues chez des rats contrOles, avec simulacre de traitement,
nourris de facon appariée (PF). Ici encore, C1,, (4,22 ml mn' .kg
chezlesPFcontre2,69chezlesCA),RPF(l6,lml inn' . kg_I contre
8,3) et Pgc (48 mm Hg contre 38) étaient diminués, et Ia résistance
vasculaire rénale (4,9 mm Hg/mi contre 8,0) était augmentée. La
récupération de 3H-inuiine dans les urines était iegerement, mais
significativement diminuée (96% contre 83%). Ces résultats demontrent
qu'Amp diminue Ia fonction rénale par au moms deux mécanismes. Une
élévation de Ia résistance vasculaire rénale est trés importante, mais
une augmentation de Ia perméabilité tubulaire avec une 'fuite" de
fluide tubulaire contribue aussi au dysfonctionnement renal, surtout
aprés Amp intraveineux.
Amphotericin B is still the most useful agent for treating
systemic mycotic infections, but drug-induced nephrotoxicity
limits its therapeutic usefulness. Yet, to date, we know almost
nothing about how the drug damages the kidney. In addition to
its clinical relevance, Amp-induced nephrotoxicity is also of
physiologic interest for at least two reasons: First, unlike most
types of experimental acute renal failure (ARF), kidney func-
tion deteriorates slowly and predictably, allowing us to deter-
mine whether or not the responsible mechanisms change with
time. Second, amphotericin increases the permeability of many
biologic membranes, and a similar effect on tubule permeability
may play a role in mediating its injurious effects on the kidney.
We developed two models of Amp nephrotoxicity in the rat.
In one, we studied the animals before and after receiving a
single dose of the drug by intravenous infusion. In the other, we
studied the rats after 4 days of intraperitoneal drug administra-
tion and compared the function of these animals with that of
pairfed rats, which had been injected with the Amp solvent
vehicle. The data reveal that Amp decreases renal function in at
least two ways. Shortly after acute intravenous administration,
tubule permeability is increased dramatically by some mecha-
nism other than renal tubule cell necrosis. After more prolonged
treatment, although the tubules are slightly more permeable,
increased afferent resistance and decreased effective glomerular
filtration pressure are the primary causes of impaired renal
function.
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Methods
We performed studies on 92 female Sprague-Dawley rats
weighing between 200 and 270 g. We anesthetized the animals
with mactin (Promonta, Hamburg, West Germany) 100 mg/kg
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i.p. and prepared them for clearance and micropuncture studies
as previously described [1]. Briefly, we inserted small polyeth-
ylene (PE) catheters into a femoral artery to measure blood
pressure and to collect blood samples, into a femoral vein to
administer drugs and solutions, into the left ureter and bladder
to collect urine from each kidney, and into the trachea to assist
spontaneous respiration. We utilized the left kidney, which was
stabilized on a lucite holding dish, for all micropuncture studies.
In some rats, we inserted a PE1O catheter into the left renal vein
as described below. In these animals, we collected renal venous
blood samples to measure the renal extraction of para-amino-
hippuric acid (PAH) which was then used to calculate renal
plasma flow (RPF).
Experimental study groups
Acute Amp (AA) rats. We gave a single dose of Amp to 28
rats by intravenous infusion. We dissolved the drug, (lot
number 7D543, E. R. Squibb & Sons, Inc., Princeton, New
Jersey) in a 5% glucose solution and infused it at a rate of 0.015
mI/mm over a 1-hr period to administer a total dose of 1 mg/kg.
We divided these rats into two subgroups. In the first subgroup
of 16 rats (AA1), we placed a catheter into the renal vein and
measured the clearance of inulin (C1) as well as the clearance
(CPAH) and the extraction of PAH (EPAH). We measured renal
function both before and after the infusion of Amp in 11 of these
16 rats with renal venous catheters (AA1a). In 6 of these 11 AA1a
rats we performed only clearance studies, but in the other 5
AAia rats, we performed clearance studies, and we also mea-
sured free-flow and single nephron stop-flow pressures as
discussed below. These 11 AA1a rats served as their own
control in that we performed the measurements before, as well
as during and after, Amp infusion. In the five remaining animals
in this subgroup of 16 rats, with renal venous catheters (AAJb),
we administered the Amp under ether anesthesia and allowed
the animals to recover. We then performed clearance studies
under mactin anesthesia 24 hr later.
In the second subgroup of nine rats, which received Amp
intravenously (AA2), we measured the permeability of the
tubular epithelium to radioactive inulin and mannitol utilizing
the microinjection technique described below. We also per-
formed these permeability measurements before and after infus-
ing the drug but did not measure C, CPAH, and EPAH in these
rats.
We studied the effects of acute intravenous Amp on renal
histology in three additional rats. After infusing the drug, we
prepared the kidneys for histologic examination by dripping
warmed glutaraldehyde-formaldehyde over the surface of the
kidney for 1 hr in vivo. After this drip fixation, the kidneys were
postfixed in 1% osmium tetroxide for an additional 2 hr.
Sections of tissue were dehydrated with a graded series of
alcohols and infiltrated with Epon resin, 1-es thick sections were
cut and stained with toluidine blue. In one animal, we fixed the
kidney immediately after completing the infusion; in the other
animals we fixed the kidney 2 and 4 hr later.
Chronic-Amp (CA) rats. We injected 34 rats with Amp over a
4-day period. We instilled 10 mg/kg into the peritoneal cavity
every day via a permanently implanted silicon rubber catheter.
Two days before treatment, we placed this catheter into the
peritoneal cavity and tunneled it subcutaneously to an exit site
at the back of the neck. We fed these rats twice daily by gastric
lavage, because preliminary studies revealed that they did not
eat well as renal failure developed. Their diet consisted of milk
supplemented with sodium chloride so that daily salt intake
approximated that normally achieved from the ingestion of
standard rat chow. We allowed the rats free access to tap water.
We also divided these 34 rats into two subgroups. In the first
subgroup (CA1), consisting of 17 rats, we measured C, CPAH,
and EPAH. In 10 of the 17 rats in this CA1 subgroup (CA1a), we
also measured intratubular pressures. In the second subgroup
(CA2), also consisting of 17 rats, we measured tubule perme-
ability. As in AA2 rats, we did not measure renal clearances or
PAH extraction in these CA2 rats studied by microinjection
techniques.
Pairfed (PF) control rats. We evaluated the effect of chronic
Amp administration on renal function by comparing the data
from CA rats with data from 34 age-matched pairfed-control
rats. For 4 days, we instilled the Amp solvent vehicle, a 5%
solution of glucose, into the peritoneal cavity of these PF rats,
which, like CA rats, were also fed by gastric lavage. In both the
CA and PF rats, after the drug or its solvent vehicle was
instilled, we filled the silicone catheter with a solution of
chloramphenicol in saline and ligated it to prevent bacterial
contamination of the peritoneum. We also divided these PF rats
into two subgroups. In the 19 rats in the PF1 subgroup (PF1a),
we measured C1, CPAH, and EPAH. In 10 of these 19 PF1 rats
we also measured intratubular pressures. In the second sub-
group, consisting of 15 rats (PF2), we measured tubule perme-
ability to inulin and mannitol. As in AA2 and CA2, we did not
measure C1, CPAH, or EPAH.
Experimental techniques
Clearance studies with measurements of PAH extraction. We
inserted renal venous catheters in 16 acute-Amp (AA1), 17
chronic-Amp (CA1), and 19 pairfed-control rats (PF1). These
rats received 0.5 ml of Ringer's lactate solution containing
(carboxyl)4C)-inulin (In, 1.0 MCi) and (Glycl-3H)-PAH (3.0
sCi) to rapidly elevate plasma radioactivity. We then adminis-
tered a sustaining infusion of Ringer's lactate solution contain-
ing 14C-inulin (2.0 sCiIml) and 3H-PAH (20.0 Ci/ml) at a rate
of 0.1 ml min - kg' body weight to maintain the isotope
concentration at the desired levels. We collected arterial and
renal venous blood samples at the midpoint of each of the 30-
mm urine collection periods.
Micropuncture measurement of intratubular pressures. We
also measured free-flow and single-nephron stop-flow pressure
in 5 acute-Amp (AA1a), 10 chronic-Amp (CA1a), and 10 pairfed-
control (PF1a) rats by a modification of the technique described
by Gottschalk and Mylle [2]. We measured free-flow pressures
in proximal (Pr) and distal (Pd) tubules and single nephron stop-
flow (PSf) pressures in the earliest surface convolutions of
proximal tubules after filling the later proximal convolutions
with colored castor oil. We performed all measurements of
intratubular pressure with a servonulling micropressure trans-
ducer (Model 900 Micropressure Systems, W-P Instruments,
Inc., New Haven, Connecticut). To utilize Psf to assess the
ultrafiltration pressure at the afferent end of the glomerular
capillaries (Pufa), we estimated arterial oncotic pressure (lTa)
utilizing the Landis-Pappenheimer equation [3] from the mea-
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sured plasma protein concentration. We verified the validity of
this estimate in a number of rats by direct measurement utilizing
a colloid osmometer constructed according to the method of
Aukland and Johnsen [4].
Micropuncture microinjection studies. We assessed the integ-
rity of the renal tubule epithelium by a modification of the
microinjection technique of Gottschalk, Morel, and Mylle [5].
Weperformed these studies in nine acute-Amp rats (AA2; six of
these nine animals were injected before Amp, four rats received
one post-Amp and five received two post-Amp injections), 17
chronic-Amp rats (CA2; 10 received one injection, seven re-
ceived two), and 15 pairfed-control rats (PF2; 13 received one
injection, two received two). These animals were prepared for
micropuncture without renal venous catheters. To increase
urine flow in these animals, we administered a solution of
mannitol (5 g/dl) and NaCl (0.9 gIdl) at a rate of 0.70
ml min kg body weight. We cannulated both ureters of
these animals with short lengths of PE-50 tubing and bathed the
left kidney with heated mineral oil. The injectate contained 0.25
mCi/mi of both 3H-inulin and '4C-mannitol in a solution of NaC1
(150mM), KCI (5 mM), and F, D, and C green food dye (0.1%).
We injected 3 nl of this solution into randomly selected proxi-
mal tubules over 1 to 2 mm, carefully avoiding any retrograde
perfusion of the tubule. We collected the urine from both
kidneys directly into preweighed counting vials. We began
collecting the urine just before we injected the isotopes and
continued the collections for at least 10 mm. in the acute-Amp
(AA2) rats, we collected urine for an additional 20 mm. When
rats were injected more than once, different surface nephrons
were chosen for each injection.
Calculations. We calculated C1 and CPAH in the usual
manner. We calculated RPF as CPAH/EPAH and renal blood flow
(RBF) as RPF/(1-Hct). We also calculated the apparent filtra-
tion fraction (FF) as C1/RPF. We calculated glomerular capil-
lary hydrostatic pressure (Pgç) as follows:
gc = "sf + a (I)
We estimated the ultrafiltration pressure at the afferent end of
the glomerular capillaries (Piifa) as follows:
Pufa Pg — lTa — P1 (2)
We determined whole-kidney resistance as blood pressure (BP)
divided by RBF.
To determine if two groups of data were significantly differ-
ent, we first performed an analysis of variance, if the analysis
suggested that the individual variances of each group were
similar, we assessed the significance of difference between
means using an unpaired Student's t test with a common or
pooled variance. If the variance of the two groups differed
significantly or if visual inspection of the data suggested that the
data were not normally distributed, we divided the data into
class intervals and compared the distribution of these classes to
a normal distribution using x2 If the distributions were shown
to differ significantly from normal, we assessed the differences
between groups by a nonparametric test (Wilcoxon's two-point
discrimination test). Otherwise, we analyzed the significance of
difference between the groups by Student's t test without
pooling the individual variances [61. We expressed data as
means SEM. Probability (P) values greater than 0.05 were not
considered significant.
Analytical techniques. We measured '4C and 3H activity with
an IsoCap/300 liquid scintillation counting system (Searle Ana-
lytical, Inc., Chicago, Illinois), plasma protein concentration
with BioRad® reagent, and the concentrations of sodium and
potassium with a lithium internal standard flame photometer
(Instrumentation Laboratories, Lexington, Massachusetts).
Results
Acute-Amp rats
Tubule permeability. The percentage of the 3H-inulin and
'4C-mannitol injected into the proximal tubule that was excret-
ed in 10 mm is shown in Figure 1. When given before Amp, the
amount of isotope recovered from the injected kidney averaged
100.2 0.4% for 3H and 93.9 0.8% for '4C. When injected I
to 4 hr after Amp, only 28.4 8.1% 3H (P < 0.001) and 24.3
7.3% 'C (P < 0.001) were recovered during this initial 10 mm.
The recovery of 3H and '4C from the contralateral-noninjected
kidney averaged 0.36 0.20% and 0.61 0.15% before Amp
and 9.62 1.39% (P < 0.001) and 9.18 1.23% (P < 0.001)
after Amp. Because of the decreased recovery during the first
10 mm, urine was collected for an additional 20 mm. The 30-mm
excretion of 3H by the injected kidney averaged 44.9 7.7%;
that excreted by the contralateral kidney, 26.5 4.7%, al-
though substantial, was significantly less (P < 0.05). The
excretion of '4C-mannitol was 39.4 7.3% by the injected
kidney and 22.8 3.0% by the contralateral kidney (P < 0.05).
Even though the distribution of these data is not demonstrably
different from normal, inspection of Figure 1 suggests that it is
prudent to confirm the findings by the use of a nonparametric
statistical test. The use of Wilcoxon's test confirmed the
previous findings that the preinjection values for both 3H and
'4C differ significantly (P < 0.01) from the postinjection values
for both the injected and the contralateral kidneys.
The recovery of 3H and 14C in the post-Amp period is quite
variable. To determine if permeability changes with the passage
of time, the recovery of 3H-inulin from the injected kidney at
different periods after Amp is plotted in Figure 2. Tubule
permeability appears to increase during the 4 to 5 hr following
Amp. In all animals in which two samples were collected in the
post-Amp period, isotope recovery decreased with increasing
time.
Whole kidney function.
,
RPF, C1, the apparent filtration
fraction,1 and urine flow (V) were measured in 11 AAia rats
before, during, and 2 to 4 hr after Amp and 24 hr after Amp in
five AAIh rats. The results of these measurements are shown in
Figure 3. RPF, which was estimated from the clearance and
extraction of PAH, averaged 12.0 0.9 ml min1 kg
before Amp, decreased to 3.06 0.87 during the infusion but
rose immediately thereafter to a value not significantly different
from the preinfusion control. Thirty minutes later, it was
significantly less than control and remained depressed at ap-
proximately this same level for the next 3.5 hr. This reduction in
The term apparent filtration fraction (FF) is used because C1 does
not adequately reflect GFR under these conditions of increased tubule
permeability. FF should not be interpreted as a hemodynamic parame-
ter, but only as a nonspecific term comparing the changes in C
(decreased by increased tubule permeability) to those of RPF (not
affected by changes in permeability).
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RPF appears transient, inasmuch as values from AAIb rats
studied 24 hr after Amp were not decreased but were actually
somewhat increased. The extraction of PAH averaged 75.0
1.8% before and 74.6 2.5% 24 hr after intravenous Amp.
EPAH fell to 57.7% during the final 30 mm of the Amp infusion,
rose transiently to 62.9% immediately afterward, and then
declined to 41.8% 3 hr after infusion of the drug. C followed a
similar pattern to that of RPF, except that all values during the
4-hr postinfusion period were significantly less than control.
Unlike RPF, which was relatively stable during the early
postinfusion period, C1, decreased progressively. As a result,
FF also decreased continuously in the early postinfusion pen-
od. C1. 24 hr after Amp was restored to a level not significantly
different from control.
The pattern of urine excretion (V) differed from these hemo-
dynamic changes. Although decreased during the infusion when
RPF was most severely reduced, V increased immediately after
the infusion to control levels, and thereafter, rose in a steady
and progressive fashion. Unlike C, V 24 hr after Amp was not
normal; it was significantly elevated. These changes in renal
hemodynamics and urine excretion were not due to any alter-
ation of arterial blood pressure. BP during the control period
(107 4 mm Hg) did not differ significantly from values during
the initial (108 5 mm Hg) or final 30 mm of the infusion (113
5 mm Hg), nor from BP 30 to 180 mm (111 4 mm Hg) after
Amp.
Pressure determinants of GFR. The pressure determinants of
GFR were measured in five AAia rats both before and 1 to 2 hr
after Amp. The results are shown in Fig. 4A. When pre- and
postinfusion values were compared, no change in either P or lTa
was noted (P1 pre, 12.0 0.3 mm Hg vs. post, 10.5 0.6; ir
pre, 10.5 0.7 vs. post, 9.9 0.5). But Psf, Pgc, and Pufa all
decreased significantly (P5f pre, 41.6 0.8mm Hg vs. post, 29.8
1.5; Pgcpre, 52.2 post, 39.7 l.9;andPufapre, 30.1
0.8 vs. post, 19.0 1.5; in all P < 0.01). Whole kidney
resistance was also calculated for this period. While RBF
decreased from 22.6 2.57 ml min' . kg_i during the control
period to 12.24 2.1 after Amp, BP did not change. Thus,
whole kidney resistance increased significantly (pre, 5.17
0.57 mm Hg/mi vs. post, 12.0 2.11; P < 0.02).
Morphologic studies
To study the mechanism by which permeability is increased
in the immediate postinfusion period, three additional rats were
treated with Amp and their kidneys fixed immediately or 2 hr
later to examine tubule morphology. Histologic abnormalities
immediately after receiving Amp were mild and limited to a
somewhat ragged appearance of the brush border and a slight
increase in apical vacuolization in all proximal tubules. Two to
three hours later, at the time when the permeability studies had
been performed, even these mild abnormalities were no longer
apparent. This appearance was uniform throughout the area of
fixation. Careful examination failed to reveal any evidence of
tubule cell necrosis.
Chronic-Amp rats
Microinjection studies. The recovery of the 3H-inulin and
'4C-mannitol injected into proximal tubules of CA and PF-
control rats is seen in Figure 5. The distribution of the data from
the injected kidney is significantly different from normal, and
thus, these data were analyzed only by a nonparametric test. In
the PF-control rats, the recovery of 3H (95.7 1.9%) and '4C
(94.3 1.2%) from the injected kidney was significantly greater
than that from CA rats (3H, 82.8 5.4%, P < 0.006; '4C, 79.12
5.6% P < 0.005). The amounts of isotope recovered from the
contralateral kidneys (3H from PF, 0.41 0.13% vs. CA, 1.55
Recovery 3H-inulin % Recovery 14C-mannitol
njected Contralateral
kidney kidney
100 F—----
80
60
40
20
V
Injected Contralateral
kidney kidney
C
C
0
C,
a,
Pre Post Pre Post Pre Post Pe Post
Fig. 1. Recovery of 3H-inulin and '4C-mannitol in the urine of the
injected and contralateral kidneys during the first 10 mm after their
injection into proximal tubules of AA rats before (pre) and 2 to 6 hr after
(post) receiving amphotericin, 1 mg/kg iv.
2 3 4 5
lime, hours post/nfusion
Fig. 2. Recovery of 3H-inulin in the urine qf the injected kidney during
the first 10 mm after its injection into proximal tubules of AA rats before
and after receiving Amp, 1 mg/kg iv. as a function of time after
injection.
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Fig. 3. Inulin clearance (C,,,), renal plasma flow (RPF), apparent
filtration fraction (FF = C,,,/RPF), and urine flow rate (V) before,
during, and I to 4 hr after administering Amp, 1 mg/kg Lv., to AA,;
and 24 hr after Amp in AAJh rats.
0.13%; '4C from PF, 0.62 0.14% vs. CA, 1.72 0.50%) were
not significantly different.
Whole kidney function. The renal hemodynamic and excre-
tory data of these CA and PF-control rats are shown in Table 1.
RPF and C1,, were both significantly reduced in the CA rats.
The extraction of PAH was also reduced from a value of 70.2
4.2% in the PF-control rats to 54.5 8.4% (P < 0.01) in CA
rats. Urine flow rate (V) and both absolute- (UN5V) and
fractional- (EFNa) sodium excretion were increased, but abso-
lute potassium excretion (UKV) was reduced.
Pressure determinants of GFR. The results of measuring
various pressures in single nephrons are shown in Figure 4B.
Although the values for lTa, P, and Pd of the CA rats were not
different from those of the PF-control animals, Psf, Pgc, and Pufa
were all significantly reduced (P5f CA, 28.6 0.8 mm Hg vs.
PF, 37.3 0.4; Pgc CA, 38.3 1,1 vs. PF, 48.1 0.5; and P,,
CA, 17.5 0.1 vs. PF, 26.0 0.6; P < 0.01).
Whole kidney resistance was also calculated. The BP of the
CA rats was lower than that of the PF-control animals (CA, 83
3 mm Hg vs. PF, 105 3; P < 0.001) at the time P was
measured. This 21% decrease in BP cannot wholly account for
the 38% decrease in RBF (PF, 22.2 2.1 ml min .kg' vs.
CA, 13.7 1.8; P < 0.001). Whole kidney resistance (PF, 4.92
0.22 mm Hg/ml vs. CA, 8.05 1.32; P < 0.01) was
significantly increased in the CA rats.
0,I
E
E
0)
=
E
C
A Effect of acute AMP
B Effect of chronic-AMP
P — NS NS NS <0.01 <0.001 <0.001
Fig. 4. Pressure determinants of GFR: A Before (pre-AMP) and Ito 2 hr
after (post-AMP) receiving amphotericin, 1 mg/kg i.v.; and B After
receiving amphotericin (10 mg/kg per day; chronic-AMP rats) or its
solvent vehicle (pair-fed control rats) i.p. daily for 4 days. Abbrevia-
tions: P, hydrostatic pressure in proximal tubules; Pd, hydrostatic
pressure in distal tubules; i, oncotic pressure in arterial blood; Psf,
early proximal stop-flow pressure; Pgc, calculated hydrostatic pressure
in glomerular capillaries; Pafa, calculated ultrafiltration pressure at the
afferent end of the glomerular capillaries.
Discussion
We administered Amp, 10 mg/kg i.p. because Gouge and
Andriole [7] had previously demonstrated that this dose will
dependably produce renal failure after a relatively brief period
of time. The dose seems quite large by human standards, but
the comparison of Amp dosages in rodents with those in man is
difficult for at least two reasons. Relative to its body weight, the
GFR of a rat is approximately seven times greater than that of a
man. Also, the plasma half-life of intraperitoneal Amp in mice is
approximately 30 mm [8] as compared with a half-life of 15 days
following an intravenous injection in man [9]. We chose to give
1.0 mg/kg i,v. because this dose should produce the same blood
concentration as 10.0 mg/kg i.p. [81. In addition, preliminary
tests in our laboratory revealed that larger intravenous dosages
tended to produce death from hyperkalemia, presumably due to
Amp-induced release of potassium by red blood cells and
muscles [101. Hyperkalemia with dosages larger than 1.0 mg/kg
seemed somewhat surprising since larger dosages have been
Pre-AMP
0 Post AMP
P, P,5 P
P = NS NS <0.001 <0.001 <0.001
Pairfed control rats
0 Chronic AMP rats
1 0 1 2 3 4 24
Time, hours
Sr P, P5 P5
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% Recovery 14C-mannitol ly, to increased afferent resistance. Although increased resist-
ance is clearly important in the pathogenesis of decreased renal
function, we cannot quantitate its contribution with absolute
certainty for at least two reasons: First, decreased filtration in
several other types of acute renal failure (ARF) results from a
decrease in the permeability coefficient (Kf) of the glomerular
capillaries [13, 14] or from a decrease in glomerular plasma flow
(GPF) [151. In this study we did not obtain the efferent arteriolar
blood samples that are needed to calculate Kf and GPF.
Second, our estimate of Pgç, based on measured proximal-
tubule stop-flow pressures, may be less than true P because of
the increased tubule permeability. Although we measured P1 in
the earliest segment of the proximal tubule, the marked increase
in permeability could have partially vented the occluded tubule,
causing us to underestimate Psf. Nevertheless, even interpret-
ing the data most conservatively, it seems reasonable to con-
clude that increased renal vascular resistance, particularly in
the afferent arterioles, is probably important in decreasing renal
function after intravenous Amp.
A second mechanism by which intravenous Amp acts to
impair renal function is by increasing tubule permeability.
Increased permeability is certainly not unique to Amp-induced
ARF. It is, superficially, not even unexpected, given that Amp
is known to increase the permeability of many biologic mem-
branes. Two facets of this permeability change are unusual,
though. First, increased permeability in other types of ARF
occurs in the setting of tubule cell necrosis [16—21]. It is not
surprising that a necrotic epithelium is permeable to inulin. The
change in permeability after Amp, however, occurs in the
absence of necrosis. Second, although Amp increases perme-
ability of both biologic [22—26] and artificial [27] membranes, its
effect on tubule permeability is quite different. The increase in
permeability of other membranes is limited to small ions and
organic molecules no larger than sucrose (342 daltons). In-
creased permeability to a molecule as large as inulin (approxi-
mately 5000 daltons) has not been described. The effect of Amp
on other tissues also occurs almost instantaneously due to an
interaction of Amp with the sterols in the plasma membrane.
The data in Figure 2 suggest that the effect of Amp on the tubule
is more delayed, tending to be maximal 3 to 4 hr after complet-
ing the infusion.
The site(s) in the tubule affected by Amp is uncertain. Distal
renal tubule acidosis secondary to Amp [7, 28, 291 suggests
increased permeability of the terminal nephron to hydrogen ion
[29]. In this study, when we infused colored saline into the
proximal tubule during the micropressure measurements, the
dye diffused out of the proximal tubule into peritubular blood
and never appeared in distal nephron segments. This finding
suggests that permeability of the proximal tubules is also
increased.
The cellular, or subcellular pathway for increased permeabili-
ty is not known. Studies in frog skin [22], toad [24], and turtle
[23] urinary bladders, as well as in Necturus gallbladder [25]
suggest that Amp increases the permeability of both the plasma
membrane and the paracellular pathway. Somewhat similar in
time of onset to our findings, the effect of Amp on the
paracellular pathway in turtle urinary bladder occurs only with
prolonged exposure to the drug [231. These data suggest that
Amp might exert its effect on the renal tubule by altering the
paracellular pathway or tight junctions. But, it should be
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Fig. 5. Ten-minute recovery of 3H-inulin and 14C-mannitol in the urine
of the injected and contralateral kidneys of rats that had received
amphotericin (CA, 10 mg/kg per day) or its solvent vehicle (PF)
intraperitoneally for 4 days. Abbreviations: PFC, pair-fed control rats;
CA, chronic Amp-B rats.
given previously to rodents without the occurrence of mortality
[1112. These findings suggest the drug lot used in the present
study may have been unusually toxic. However, variability of
toxicity between lots of Amp has been recorded previously [12].
It is clear that the noxious effect of intravenous Amp on the
kidney is mediated by several mechanisms. The immediate
effect of the drug is hemodynamic, namely a severe decrease in
RBF, in the C111, and, probably, in GFR. Shortly thereafter, a
quite remarkable increase in tubule permeability contributes to
a further decrease in C1. Under circumstances of increased
tubule permeability, one cannot estimate the true rate of
glomerular filtration from the C111. This inaccuracy, however,
may be more of a problem of semantics than of biology. The
primary purpose of filtration is to initiate the processes by
which toxic wastes are excreted and body water and electrolyte
content is modulated by the kidney. Inasmuch as both of these
activities require the selective retention of various components
of the glomerular filtrate within the lumen, such a broad-based,
nonselective increase in tubule permeability, reflected by a
further fall in inulin clearance, may be viewed as a decrease in
the effective (or biologically important) filtration rate. Finally,
both these hemodynamic and permeability changes appear
transitory, since renal function 24 hr after a single intravenous
injection had largely returned to normal.
The initial renal response to Amp was hemodynamic and
appeared related to the presence of the drug in the blood,
inasmuch as RPF increased significantly as soon as the infusion
was discontinued. One to two hours after receiving the drug,
C111 decreased, suggesting that the filtration rate was reduced.
These hemodynamic changes appear to be due, at least partial-
2 In addition, new (unpublished) studies in our laboratory, which
used a different drug lot, demonstrated that intravenous dosages of 2 to
3 mg/kg were required to produce severe hyperkalemia.
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Table 1. Renal hemodynamic and excretory function in rats treated with amphotericin (10 mg/kg iv.) for 4 days (CA) and pairfed (PF) sham-
treated control rats
PF 4.22 16.1 15.7 0.199 2.950 0.121
(N — 19) 0.4l0 0.028
CA 2.69 8.3 26.1 0.842 1.318 0.236
(N = 17) 1.6 0.04l
P <0.001 <0.01 <0.01 <0.001 <0.01 <0.05
Abbreviations: CA, chronic amphotericin-treated rats; PF, pairfed sham-treated rats: C, clearance of inulin: RPF. renal plasma flow; /, urine
flow rate; UNaV, absolute rate of sodium excretion; UKV absolute rate of potassium excretion; EFN,, fraction of filtered sodium excreted in the
urine; N, number of animals.
a Values are means SEM.
emphasized that in these other studies, the increase in transport
through the paracellular pathway is, again, restricted to mole-
cules no larger than bicarbonate [23] or urea 22]. Thus, the
applicability of these data to the present study is conjectural
only.
Cii, decreased progressively after a brief initial rise in the
immediate postinfusion period, while RPF remained at approxi-
mately the same level during this time. It is possible that this
decrease in C1n reflects a true decrease in GFR. It is also
possible that the greater decrease in Ch. than in RPF is an
artifact due to increased tubule permeability. RPF was estimat-
ed from the clearance and extraction of PAH. Although clear-
ance measurements under conditions of increased tubule per-
meability may be unreliable, the combination of clearance and
extraction techniques should obviate this problem. Filtration
was estimated only by clearance; thus any increase in perme-
ability would cause us to underestimate true GFR. The continu-
ous fall in C11, 2 to 3 hr after the infusion was concurrent with
the most dramatic increase in permeability, suggesting that
increased tubular 'leakiness" is an important contributor to the
decrease in C1,.
The apparent similarity between the 72% decrease in inulin
recovery in the AA2 rats (in 10-mm collections) and the 60 to
70% decrease in C11, 3 hr after the infusion in the AA1 rats is
interesting but of uncertain significance. A direct quantitative
attribution of the one to the other is unwise because the
experimental conditions were quite different. The microinjec-
tion studies were performed under mannitol diuresis, which
may have affected the results. Studies in the dog [30] suggest
that mannitol may decrease the nephrotoxicity of Amp. Thus,
the decrease in GFR during mannitol infusion and during
hydropenia cannot, necessarily, be assumed to be equal. Man-
nitol infusion also increases intratubular pressure, which may
increase the permeability of the tubule, at least to smaller
molecules like mannitol or creatinine [31]. Thus, tubule perme-
ability during mannitol infusion may also be different from that
during hydropenia. Even though it is unwise to try to assess the
exact quantitative contribution of increased tubule permeability
to decreased GFR, it is, nevertheless, quite clear that it plays a
major role.
To summarize, a single intravenous injection of Amp appears
to impair renal function by at least two mechanisms. There is an
early hemodynamic response, which is maximal during infusion
of the drug and continues for at least 3 to 4 hr thereafter. Near
the end of this early period, tubule permeability is increased
further reducing the effective filtration rate. Near total recovery
of renal function is observed after 24 hr, suggesting that more
lasting impairment of renal function requires repetitive dosages
of the drug.
The effects of chronic intraperitoneal administration of Amp
are similar to those observed after a single intravenous dose.
Renal hemodynamics and tubule permeability are both altered,
but the changes differ in magnitude and relative importance
from those observed in the acute study. Inulin clearance and
RPF were decreased following chronic intraperitoneal Amp.
The 41% decrease in the former is similar to the 47% decrease in
the latter. The near equality of these changes should be
contrasted with a 68% decrease in Ci,, and a 33% decrease in the
RPF 3 hr following intravenous administration. The hemody-
namic changes after chronic Amp administration can also be
attributed to two factors, First, there was a 21% decrease in
blood pressure. Second, there was also a 64% increase in whole
kidney resistance. This resistance change in CA rats is less than
the 132% increase observed after intravenous Amp, but the
lesser rise in resistance in CA rats may reflect an autoregulatory
response to the reduced blood pressure in these animals.
Tubule permeability is also increased following chronic Amp,
but the 21% decrease in inulin recovery is markedly less than
the 72% decrease after intravenous Amp. The extent to which
permeability changes contribute to the impairment of effective
filtration rate in the two models can be assessed, albeit indirect-
ly, by contrasting the relative changes in renal hemodynamics.
Three hours after intravenous Amp, the decrease in C11, was
much greater than the decrease in RPF (68% vs. 33%), whereas
the changes were nearly the same in the CA animals (41 and
47%). These findings suggest that, although increased tubule
"leakiness" is undoubtedly important shortly after receiving
the drug intravenously, its effect on the effective filtration rate
of chronically treated animals is marginal.
These studies do not exclude tubule obstruction as a cause of
decreased renal function following Amp, although neither the
measurements of intratubular pressures nor the histologic find-
ings support such a mechanism. Neither do these studies
exclude a primary change in the glomerular filtration barrier as
being important. They do demonstrate, however, that Amp
administration impairs renal function, predominantly by in-
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creasing renal vascular resistance and, secondarily, the effec-
tive filtration pressure. An increase in tubule permeability is
also noted, and is quite dramatic shortly after the drug is given
intravenously, although its role in altering renal function of
animals treated chronically is less important.
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